Antares Pharma, Inc.

RHUMBLINE ADVISERS MJC

Report date

3/31/2022

Quarter

2022 Q1

Filed

5/12/2022

Shares

188,475

Value ($000)

773

Weight

0.0%

2013 Q4 - 2022 Q1 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q1	5/12/2022	773	0.0%	188,475	3/31/2022
2021 Q4	2/10/2022	673	0.0%	188,613	12/31/2021
2021 Q3	11/12/2021	946	0.0%	259,935	9/30/2021
2021 Q2	8/5/2021	1,241	0.0%	284,654	6/30/2021
2021 Q1	5/6/2021	1,098	0.0%	267,136	3/31/2021
2020 Q4	2/10/2021	1,120	0.0%	280,816	12/31/2020
2020 Q3	11/12/2020	705	0.0%	260,961	9/30/2020
2020 Q2	8/13/2020	767	0.0%	278,741	6/30/2020
2020 Q1	5/6/2020	523	0.0%	221,650	3/31/2020
2019 Q4	2/5/2020	1,047	0.0%	222,750	12/31/2019
2014 Q2	8/6/2014	249	0.0%	93,133	6/30/2014
2014 Q1	5/6/2014	332	0.0%	94,965	3/31/2014
2013 Q4	2/3/2014	450	0.0%	100,465	12/31/2013